XML 48 R28.htm IDEA: XBRL DOCUMENT
v3.24.4

Pension and Other Benefit Plans | 12 Months Ended
--- | ---
Dec. 31, 2024
Retirement Benefits [Abstract] |
Pension and Other Benefit Plans | 17. Pension and Other Postretirement Benefit Plans Pension Plans SLB sponsors several defined benefit pension plans that cover substantially all US employees hired prior to October 1, 2004. The benefits are based on years of service and compensation, on a career-average pay basis. In addition to the US defined benefit pension plans, SLB sponsors several other international defined benefit pension plans. The most significant of these international plans are the International Staff Pension Plan and the UK pension plan (collectively, the “International plans”). The International Staff Pension Plan covers certain international employees hired prior to July 1, 2014 and is based on years of service and compensation on a career-average pay basis. The UK plan covers employees hired prior to April 1, 1999, and is based on years of service and compensation, on a final salary basis. The weighted-average assumed discount rate, compensation increases and expected long-term rate of return on plan assets used to determine the net pension cost for the US and International plans were as follows:
| US |  |  | International |
| 2024 |  |  | 2023 |  |  | 2022 |  |  | 2024 |  |  | 2023 |  |  | 2022 |
Discount rate |  | 5.25 | % |  |  | 5.50 | % |  |  | 3.00 | % |  |  | 5.14 | % |  |  | 5.41 | % |  |  | 2.83 | %
Compensation increases |  | 4.00 | % |  |  | 4.00 | % |  |  | 4.00 | % |  |  | 4.84 | % |  |  | 4.84 | % |  |  | 4.83 | %
Return on plan assets |  | 6.00 | % |  |  | 6.00 | % |  |  | 4.40 | % |  |  | 5.91 | % |  |  | 6.00 | % |  |  | 5.05 | %
Net pension cost (credit) included the following components:
(Stated in millions) |
| US |  |  | International |
| 2024 |  |  | 2023 |  |  | 2022 |  |  | 2024 |  |  | 2023 |  |  | 2022 |
Service cost | $ | 23 |  |  | $ | 23 |  |  | $ | 37 |  |  | $ | 56 |  |  | $ | 54 |  |  | $ | 101 |
Interest cost |  | 173 |  |  |  | 178 |  |  |  | 137 |  |  |  | 413 |  |  |  | 407 |  |  |  | 298 |
Expected return on plan assets |  | (200 | ) |  |  | (198 | ) |  |  | (202 | ) |  |  | (553 | ) |  |  | (607 | ) |  |  | (530 | )
Amortization of net loss |  | - |  |  |  | - |  |  |  | 5 |  |  |  | 10 |  |  |  | - |  |  |  | 80 |
| $ | (4 | ) |  | $ | 3 |  |  | $ | (23 | ) |  | $ | (74 | ) |  | $ | (146 | ) |  | $ | (51 | )
The weighted-average assumed discount rate and compensation increases used to determine the projected benefit obligations for the US and International plans were as follows:
| US |  |  | International |
| 2024 |  |  | 2023 |  |  | 2024 |  |  | 2023 |
Discount rate |  | 5.70 | % |  |  | 5.25 | % |  |  | 5.67 | % |  |  | 5.14 | %
Compensation increases |  | 4.00 | % |  |  | 4.00 | % |  |  | 4.85 | % |  |  | 4.84 | %
The changes in the projected benefit obligation, plan assets and funded status of the plans were as follows:
(Stated in millions) |
| US |  |  | International |
| 2024 |  |  | 2023 |  |  | 2024 |  |  | 2023 |
Change in Projected Benefit Obligations: |  |  |  |  |  |  |  |  |  |  |
Projected benefit obligation at beginning of year | $ | 3,413 |  |  | $ | 3,315 |  |  | $ | 8,109 |  |  | $ | 7,598 |
Service cost |  | 23 |  |  |  | 23 |  |  |  | 56 |  |  |  | 54 |
Interest cost |  | 173 |  |  |  | 178 |  |  |  | 413 |  |  |  | 407 |
Contribution by plan participants |  | - |  |  |  | - |  |  |  | 61 |  |  |  | 52 |
Actuarial losses (gains) |  | (160 | ) |  |  | 117 |  |  |  | (457 | ) |  |  | 302 |
Currency effect |  | - |  |  |  | - |  |  |  | (2 | ) |  |  | 56 |
Benefits paid |  | (224 | ) |  |  | (220 | ) |  |  | (384 | ) |  |  | (360 | )
Projected benefit obligation at end of year | $ | 3,225 |  |  | $ | 3,413 |  |  | $ | 7,796 |  |  | $ | 8,109 |
Change in Plan Assets: |  |  |  |  |  |  |  |  |  |  |
Plan assets at fair value at beginning of year | $ | 3,427 |  |  | $ | 3,396 |  |  | $ | 8,390 |  |  | $ | 8,126 |
Actual return on plan assets |  | (38 | ) |  |  | 242 |  |  |  | (408 | ) |  |  | 494 |
Currency effect |  | - |  |  |  | - |  |  |  | (2 | ) |  |  | 71 |
Company contributions |  | 10 |  |  |  | 9 |  |  |  | 17 |  |  |  | 7 |
Contributions by plan participants |  | - |  |  |  | - |  |  |  | 61 |  |  |  | 52 |
Benefits paid |  | (224 | ) |  |  | (220 | ) |  |  | (384 | ) |  |  | (360 | )
Plan assets at fair value at end of year | $ | 3,175 |  |  | $ | 3,427 |  |  | $ | 7,674 |  |  | $ | 8,390 |
Asset / (Unfunded Liability) | $ | (50 | ) |  | $ | 14 |  |  | $ | (122 | ) |  | $ | 281 |
Amounts Recognized in Balance Sheet: |  |  |  |  |  |  |  |  |  |  |
Postretirement Benefits | $ | (154 | ) |  | $ | (159 | ) |  | $ | (358 | ) |  | $ | (16 | )
Other Assets |  | 104 |  |  |  | 173 |  |  |  | 236 |  |  |  | 297 |
| $ | (50 | ) |  | $ | 14 |  |  | $ | (122 | ) |  | $ | 281 |
Amounts Recognized in Accumulated Other Comprehensive Loss: |  |  |  |  |  |  |  |  |  |  |
Actuarial losses | $ | 405 |  |  | $ | 328 |  |  | $ | 2,296 |  |  | $ | 1,804 |
Accumulated benefit obligation | $ | 3,137 |  |  | $ | 3,313 |  |  | $ | 7,634 |  |  | $ | 7,942 |
The asset represents the difference between the plan assets and the projected benefit obligation (“PBO”). The PBO represents the actuarial present value of benefits based on employee service and compensation and includes an assumption about future compensation levels. The accumulated benefit obligation represents the actuarial present value of benefits based on employee service and compensation but does not include an assumption about future compensation levels. Actuarial gains and losses arising during 2024 and 2023 were primarily attributable to changes in the discount rate used to determine the PBO. The weighted-average allocation of plan assets as of December 31, 2024 and 2023 and the target allocations by asset category as of December 31, 2024 were as follows:
| US |  |  |  | International |  |
| Target |  |  |  | 2024 |  |  |  | 2023 |  |  |  | Target |  |  |  | 2024 |  |  |  | 2023 |  |
Cash and cash equivalents | 0 - 3 |  | % |  |  | 1 |  | % |  |  | 1 |  | % |  | 0 - 5 |  | % |  |  | 1 |  | % |  |  | 3 |  | %
Equity securities | 0 - 5 |  |  |  |  | 2 |  |  |  |  | - |  |  |  | 0 - 5 |  |  |  |  | 3 |  |  |  |  | 1 |  |
Debt securities | 80 - 90 |  |  |  |  | 82 |  |  |  |  | 84 |  |  |  | 60 - 70 |  |  |  |  | 69 |  |  |  |  | 69 |  |
Private equity and real estate | 5 - 12 |  |  |  |  | 9 |  |  |  |  | 10 |  |  |  | 15 - 20 |  |  |  |  | 17 |  |  |  |  | 17 |  |
Private debt | 2 - 8 |  |  |  |  | 6 |  |  |  |  | 5 |  |  |  | 9 - 15 |  |  |  |  | 10 |  |  |  |  | 10 |  |
|  | 100 |  | % |  |  | 100 |  | % |  |  | 100 |  | % |  |  | 100 |  | % |  |  | 100 |  | % |  |  | 100 |  | %
The expected rate of return on assets assumptions reflect the long-term average rate of return expected to be earned on plan assets. The assumptions have been determined based on expectations regarding future rates of return for the portfolio considering the asset allocation and related historical rates of return. The appropriateness of the assumptions is reviewed annually. The fair value of SLB’s pension plan assets at December 31, 2024 and 2023, by asset category, is presented below and was determined based on valuation techniques categorized as follows: • Level One: The use of quoted prices in active markets for identical instruments. • Level Two: The use of quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active or other inputs that are observable in the market or can be corroborated by observable market data. • Level Three: The use of significant unobservable inputs that typically require the use of management’s estimates of assumptions that market participants would use in pricing.
(Stated in millions) |
| US Plan Assets |
| 2024 |  |  | 2023 |
|  |  |  | Level |  |  | Level |  |  | Level |  |  |  |  |  | Level |  |  | Level |  |  | Level |
| Total |  |  | One |  |  | Two |  |  | Three |  |  | Total |  |  | One |  |  | Two |  |  | Three |
Asset Category: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Cash and Cash Equivalents | $ | 33 |  |  | $ | 33 |  |  | $ | - |  |  | $ | - |  |  | $ | 33 |  |  | $ | 33 |  |  | $ | - |  |  | $ | - |
Equity Securities |  | 70 |  |  |  | 58 |  |  |  | 12 |  |  |  | - |  |  |  | 6 |  |  |  | - |  |  |  | 6 |  |  |  | - |
Debt Securities: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Corporate bonds |  | 1,713 |  |  |  | - |  |  |  | 1,713 |  |  |  | - |  |  |  | 1,540 |  |  |  | - |  |  |  | 1,540 |  |  |  | - |
Government and related debt securities |  | 861 |  |  |  | 13 |  |  |  | 848 |  |  |  | - |  |  |  | 1,334 |  |  |  | 163 |  |  |  | 1,171 |  |  |  | - |
Other |  | 13 |  |  |  | - |  |  |  | 13 |  |  |  | - |  |  |  | 12 |  |  |  | - |  |  |  | 12 |  |  |  | - |
Alternative Investments: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Private equity |  | 234 |  |  |  | - |  |  |  | - |  |  |  | 234 |  |  |  | 287 |  |  |  | - |  |  |  | - |  |  |  | 287 |
Private debt |  | 186 |  |  |  | - |  |  |  | - |  |  |  | 186 |  |  |  | 148 |  |  |  | - |  |  |  | - |  |  |  | 148 |
Real estate |  | 65 |  |  |  | - |  |  |  | - |  |  |  | 65 |  |  |  | 67 |  |  |  | - |  |  |  | - |  |  |  | 67 |
Total | $ | 3,175 |  |  | $ | 104 |  |  | $ | 2,586 |  |  | $ | 485 |  |  | $ | 3,427 |  |  | $ | 196 |  |  | $ | 2,729 |  |  | $ | 502 |
(Stated in millions) |
| International Plan Assets |
| 2024 |  |  | 2023 |
|  |  |  | Level |  |  | Level |  |  | Level |  |  |  |  |  | Level |  |  | Level |  |  | Level |
| Total |  |  | One |  |  | Two |  |  | Three |  |  | Total |  |  | One |  |  | Two |  |  | Three |
Asset Category: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Cash and Cash Equivalents | $ | 90 |  |  | $ | 89 |  |  | $ | 1 |  |  | $ | - |  |  | $ | 267 |  |  | $ | 260 |  |  | $ | 7 |  |  | $ | - |
Equity Securities |  | 264 |  |  |  | 264 |  |  |  |  |  |  |  |  |  | 122 |  |  |  | 122 |  |  |  |  |  |  |
Debt Securities: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Corporate bonds |  | 2,948 |  |  |  | - |  |  |  | 2,948 |  |  |  | - |  |  |  | 3,001 |  |  |  | - |  |  |  | 3,001 |  |  |  | - |
Government and related debt securities |  | 1,969 |  |  |  | 448 |  |  |  | 1,521 |  |  |  | - |  |  |  | 2,466 |  |  |  | 563 |  |  |  | 1,903 |  |  |  | - |
Other |  | 390 |  |  |  | - |  |  |  | 390 |  |  |  | - |  |  |  | 292 |  |  |  | - |  |  |  | 292 |  |  |  | - |
Alternative Investments: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Private equity |  | 1,136 |  |  |  | - |  |  |  | - |  |  |  | 1,136 |  |  |  | 1,269 |  |  |  | - |  |  |  | - |  |  |  | 1,269 |
Private debt |  | 738 |  |  |  | - |  |  |  | - |  |  |  | 738 |  |  |  | 805 |  |  |  | - |  |  |  | - |  |  |  | 805 |
Real estate |  | 139 |  |  |  | - |  |  |  | - |  |  |  | 139 |  |  |  | 168 |  |  |  | - |  |  |  | - |  |  |  | 168 |
Total | $ | 7,674 |  |  | $ | 801 |  |  | $ | 4,860 |  |  | $ | 2,013 |  |  | $ | 8,390 |  |  | $ | 945 |  |  | $ | 5,203 |  |  | $ | 2,242 |
SLB’s funding policy is to contribute amounts that are based upon a number of factors including the funded status of the plans, amounts that are deductible for income tax purposes, legal funding requirements, and available cash flow. SLB does not expect to make any material contributions to its postretirement benefit plans in 2025. Postretirement Benefits Other Than Pensions SLB provides healthcare benefits to certain former US employees who have retired. The actuarial assumptions used to determine the accumulated postretirement benefit obligation and net periodic benefit cost for the US postretirement medical plan were as follows:
| Benefit Obligation |  |  | Net Periodic Benefit |
| At December 31, |  |  | Cost for the Year |
| 2024 |  |  | 2023 |  |  | 2024 |  |  | 2023 |  |  | 2022 |
Discount rate |  | 5.25 | % |  |  | 5.25 | % |  |  | 5.25 | % |  |  | 5.50 | % |  |  | 3.00 | %
Return on plan assets | - |  |  | - |  |  |  | 4.43 | % |  |  | 4.41 | % |  |  | 2.94 | %
Current medical cost trend rate |  | 7.25 | % |  |  | 7.50 | % |  |  | 7.25 | % |  |  | 7.50 | % |  |  | 6.75 | %
Ultimate medical cost trend rate |  | 4.50 | % |  |  | 4.50 | % |  |  | 4.50 | % |  |  | 4.50 | % |  |  | 4.50 | %
Year that the rate reaches the ultimate trend rate |  | 2035 |  |  |  | 2035 |  |  |  | 2035 |  |  |  | 2035 |  |  |  | 2031 |
The net credit for the US postretirement medical plan included the following components:
(Stated in millions) |
| 2024 |  |  | 2023 |  |  | 2022 |
Service cost | $ | 19 |  |  | $ | 16 |  |  | $ | 23 |
Interest cost |  | 41 |  |  |  | 42 |  |  |  | 33 |
Expected return on plan assets |  | (42 | ) |  |  | (41 | ) |  |  | (38 | )
Amortization of prior service credit |  | (23 | ) |  |  | (23 | ) |  |  | (23 | )
Amortization of net gain |  | (13 | ) |  |  | (12 | ) |  |  | (10 | )
| $ | (18 | ) |  | $ | (18 | ) |  | $ | (15 | )
The changes in the accumulated postretirement benefit obligation, plan assets and funded status were as follows:
(Stated in millions) |
| 2024 |  |  | 2023 |
Change in Accumulated Postretirement Benefit Obligation: |  |  |  |  |
Benefit obligation at beginning of year | $ | 805 |  |  | $ | 808 |
Service cost |  | 19 |  |  |  | 16 |
Interest cost |  | 41 |  |  |  | 42 |
Contribution by plan participants |  | 6 |  |  |  | 7 |
Actuarial gains |  | (37 | ) |  |  | (7 | )
Benefits paid |  | (53 | ) |  |  | (61 | )
Benefit obligation at end of year | $ | 781 |  |  | $ | 805 |
Change in Plan Assets: |  |  |  |  |
Plan assets at fair value at beginning of year | $ | 964 |  |  | $ | 938 |
Actual return on plan assets |  | 1 |  |  |  | 87 |
Contributions by plan participants |  | 6 |  |  |  | 7 |
Benefits paid |  | (58 | ) |  |  | (68 | )
Plan assets at fair value at end of year | $ | 913 |  |  | $ | 964 |
Asset | $ | 132 |  |  | $ | 159 |
Amounts Recognized in Accumulated Other Comprehensive Loss: |  |  |  |  |
Actuarial gains | $ | 224 |  |  | $ | 239 |
Prior service credit |  | 13 |  |  |  | 36 |
| $ | 237 |  |  | $ | 275 |
The asset balance relating to this plan was included in Other Assets in the Consolidated Balance Sheet. The assets of the US postretirement medical plan are invested 85% in debt securities and 15% in equity securities at December 31, 2024. The fair value of these assets was primarily determined based on Level Two valuation techniques. Other Information The expected benefits to be paid under the US and International pension plans as well as the postretirement medical plan are as follows:
(Stated in millions) |
| Pension Plans |  |  | Postretirement |
| US |  |  | International |  |  | Medical Plan |
2025 | $ | 230 |  |  | $ | 423 |  |  | $ | 49 |
2026 | $ | 233 |  |  | $ | 437 |  |  | $ | 50 |
2027 | $ | 232 |  |  | $ | 454 |  |  | $ | 51 |
2028 | $ | 233 |  |  | $ | 469 |  |  | $ | 53 |
2029 | $ | 234 |  |  | $ | 475 |  |  | $ | 55 |
2030-2034 | $ | 1,180 |  |  | $ | 2,591 |  |  | $ | 310 |

X
- References No definition available. + Details
Name: | us-gaap_CompensationAndRetirementDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for retirement benefits. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 715 -SubTopic 70 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480794/715-70-50-1 Reference 2: http://www.xbrl.org/2003/role/exampleRef -Topic 715 -SubTopic 20 -Name Accounting Standards Codification -Section 55 -Paragraph 17 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480482/715-20-55-17 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 715 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (d)(iv)(03) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 715 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (d)(i) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 715 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (q) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 715 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (l) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 715 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/715/tableOfContent Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 715 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (d)(iii) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 715 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (o) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 715 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (p) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1 Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Topic 715 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (r)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1 Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Topic 715 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (r)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1 Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Topic 715 -SubTopic 20 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480126/715-20-S99-2 Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Topic 715 -SubTopic 60 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480266/715-60-50-3 + Details
Name: | us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration